Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Little is known about the role of primary cilia in preinvasive and invasive prostate cancer. However, reduced cilia expression has been observed in human cancers including pancreatic cancer, renal cell carcinoma, breast cancer, cholangiocarcinoma, and melanoma. The aim of this study was to characterize primary cilia expression in preinvasive and invasive human prostate cancer, and to investigate the correlation between primary cilia and the Wnt signaling pathway. Human prostate tissues representative of stages of prostate cancer formation (normal prostate, prostatic intraepithelial neoplasia (PIN), and invasive prostate cancer (including perineural invasion)) were stained for ciliary proteins. The frequency of primary cilia was determined. A decrease in the percentage of ciliated cells in PIN, invasive cancer and perineural invasion lesions was observed when compared to normal. Cilia lengths were also measured to indirectly test functionality. Cilia were shorter in PIN, cancer, and perineural invasion lesions, suggesting dysfunction. Primary cilia have been shown to suppress the Wnt pathway. Increased Wnt signaling has been implicated in prostate cancer. Therefore, we investigated a correlation between loss of primary cilia and increased Wnt signaling in normal prostate and in preinvasive and invasive prostate cancer. To investigate Wnt signaling in our cohort, serial tissue sections were stained for β-catenin as a measure of Wnt signaling. Nuclear β-catenin was analyzed and Wnt signaling was found to be higher in un-ciliated cells in the normal prostate, PIN, a subset of invasive cancers, and perineural invasion. Our results suggest that cilia normally function to suppress the Wnt signaling pathway in epithelial cells and that cilia loss may play a role in increased Wnt signaling in some prostate cancers. These results suggest that cilia are dysfunctional in human prostate cancer, and increase Wnt signaling occurs in a subset of cancers.
References
[1]
Pazour GJ, Agrin N, Leszyk J, Witman GB (2005) Proteomic analysis of a eukaryotic cilium. Journal of Cell Biology 170: 103-113.
[2]
Corbit KC, Shyer AE, Dowdle WE, Gaulden J, Singla V et al. (2008) Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms (vol 10, pg 70, 2008). Nat Cell Biol 10: 497-497. doi:10.1038/ncb0408-497a.
[3]
Lancaster MA, Schroth J, Gleeson JG (2011) Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat Cell Biol 13: 700-U173. PubMed: 21602792.
[4]
Lancaster MA, Gleeson JG (2009) The primary cilium as a cellular signaling center: lessons from disease. Curr Opin Genet Dev 19: 220-229. doi:10.1016/j.gde.2009.04.008. PubMed: 19477114.
[5]
Han YG, Kim HJ, Dlugosz AA, Ellison DW, Gilbertson RJ et al. (2009) Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med 15: 1062-U1114. doi:10.1038/nm.2020. PubMed: 19701203.
[6]
Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK et al. (2009) Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 15: 1055-U1109. doi:10.1038/nm.2011. PubMed: 19701205.
[7]
Yuan K, Frolova N, Xie Y, Wang D, Cook L et al. (2010) Primary Cilia Are Decreased in Breast Cancer: Analysis of a Collection of Human Breast Cancer Cell Lines and Tissues. J Histochem Cytochem 58: 857-870. doi:10.1369/jhc.2010.955856. PubMed: 20530462.
[8]
Schraml P, [!(surname)!] , Thoma CR, Boysen G, Struckmann K, Krek W, Moch H (2009) Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod Pathol 22: 31-36. PubMed: 18660794.
[9]
Kim J, Dabiri S, Seeley ES (2011) Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma. PLOS ONE 6: e27410. PubMed: 22096570.
[10]
Seeley ES, Carrière C, Goetze T, Longnecker DS, Korc M (2009) Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia. Cancer Res 69: 422-430. doi:10.1158/0008-5472.CAN-08-1290. PubMed: 19147554.
[11]
SA G, BN R, PS B, BQ H, GB G, et al. (2013). p. HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Research.
[12]
Epstein JI, Allsbrook WC, Amin MB, Egevad LL, Comm IG (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29: 1228-1242. doi:10.1097/01.pas.0000173646.99337.b1. PubMed: 16096414.
[13]
Pan J, Snell W (2007) The primary cilium: Keeper of the key to cell division. Cell 129: 1255-1257. doi:10.1016/j.cell.2007.06.018. PubMed: 17604715.
[14]
Scholzen T, Gerdes J (2000) The Ki-67 protein: From the known and the unknown. J Cell Physiol 182: 311–22. PubMed: 10653597.
[15]
Long RM, Morrissey C, Fitzpatrick JM, Watson RW (2005) Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin Sci 108: 1–11. PubMed: 15384949.
[16]
Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM et al. (1992) Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52: 6182–7. PubMed: 1384957.
[17]
van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA (2001) Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 195: 563–70. PubMed: 11745692.
[18]
de Medina SGD, Salomon L, Colombel M, Abbou CC, Bellot J et al. (1998) Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer. Hum Pathol 29.
[19]
Hanahan D, Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646–74. PubMed: 21376230.
[20]
Goetz SC, Anderson KV (2010) The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 11: 331-344. doi:10.1038/nrg2774. PubMed: 20395968.
[21]
Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15: 28-32. doi:10.1038/sj.cr.7290260. PubMed: 15686623.
[22]
Chai H, Brown RE (2009) Field Effect in Cancer-An Update. Ann Clin Lab Sci 39: 331-337. PubMed: 19880759.
[23]
Kapoor A (2012) Benign prostatic hyperplasia (BPH) management in the primary care setting. Can J Urol 19 Suppl 1: 10–7. PubMed: 23089343.
[24]
Zhang J, Lipinski RJ, Gipp JJ, Shaw AK, Bushman W (2009) Hedgehog pathway responsiveness correlates with the presence of primary cilia on prostate stromal cells. BMC Dev Biol 9: 50-. PubMed: 19811645.
[25]
Ohtsuki Y, Dmochowski L (1979) Fine structure of single cilium in human prostatic neoplasia. J Clin Electron Microsc 12: 81-90.
[26]
Whitaker HC, Girling J, Warren AY, Leung H, Mills IG et al. (2008) Alterations in beta-catenin expression and localization in prostate cancer. Prostate 68: 1196-1205. doi:10.1002/pros.20780. PubMed: 18459111.
[27]
Assikis VJ, Do KA, Wen S, Wang X, Cho-Vega JH et al. (2004) Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential. Clin Cancer Res 10: 6770-6778. doi:10.1158/1078-0432.CCR-04-0275. PubMed: 15501953.
[28]
Arenas MI, Romo E, Royuela M, Fraile B, Paniagua R (2000) E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate. Histochem J 32: 659-667. doi:10.1023/A:1004111331752. PubMed: 11272805.
[29]
Horvath LG, Henshall SM, Lee CS, Kench JG, Golovsky D et al. (2005) Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. Int J Cancer 113: 415-422. doi:10.1002/ijc.20599. PubMed: 15455387.
[30]
Bismar TA, Humphrey PA, Grignon DJ, Wang HL (2004) Expression of beta-catenin in prostatic adenocarcinomas: A comparison with colorectal adenocarcinomas. Am J Clin Pathol 121: 557-563. doi:10.1309/447049GV52H7D258. PubMed: 15080308.
[31]
Chen G, Shukeir N, Potti A, Sircar K, Aprikian A et al. (2004) Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications. Cancer 101: 1345-1356. doi:10.1002/cncr.20518. PubMed: 15316903.
[32]
Aaltomaa S, K？rj？ V, Lipponen P, Isotalo T, Kankkunen JP et al. (2005) Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer. Anticancer Res 25: 4707–12. PubMed: 16334164.
[33]
Morita N, Uemura H, Tsumatani K, Cho M, Hirao Y et al. (1999) E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion. Br J Cancer 79: 1879–83. PubMed: 10206308.
[34]
Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A et al. (2005) Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 23: 402-406. doi:10.1016/j.urolonc.2005.03.024. PubMed: 16301117.
[35]
Theiss M, Wirth MP, Manseck A, Frohmüller HG (1995) Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 27: 13–7. PubMed: 7603912.
[36]
Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ et al. (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433–9. PubMed: 16046649.
[37]
Sakar I, Harada K-I, Hara I, Eto H, Miyake H (2004) Prognostic Significance？of？Capsular Invasion？and？Capsular Penetration？in？Japanese Men？with？Prostate Cancer Undergoing Radical Retropubic Prostatectomy. Urol Oncol 4: 27-30.
[38]
Morgan TM, Lange PH, Porter MP, Lin DW, Ellis WJ et al. (2009) Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence. Clin Cancer Res 15: 677-683. doi:10.1158/1078-0432.CCR-08-1754. PubMed: 19147774.
[39]
Egeberg DL, Lethan M, Manguso R, Schneider L, Awan A et al. (2012) Primary cilia and aberrant cell signaling in epithelial ovarian cancer. Cilia 1: 15-. PubMed: 23351307.
[40]
Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S et al. (2005) Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 64: 341–6. PubMed: 15754349.
[41]
Willemarck N, Rysman E, Brusselmans K, Van Imschoot G, Vanderhoydonc F et al. (2010) Aberrant Activation of Fatty Acid Synthesis Suppresses Primary Cilium Formation and Distorts Tissue Development. Cancer Res 70: 9453–62. PubMed: 20889723.
[42]
Schmidt LJ, Ballman KV, Tindall DJ (2007) Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride. Prostate 67: 1111-1120. doi:10.1002/pros.20602. PubMed: 17477363.
[43]
Goeman L, Joniau S, Ponette D, Van der Aa F, Roskams T et al. (2003) Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? Prostate Cancer Prostatic Dis 6: 305-310. doi:10.1038/sj.pcan.4500681. PubMed: 14663472.
[44]
Hassounah NB, Bunch TA, McDermott KM (2012) Molecular Pathways: The Role of Primary Cilia in Cancer Progression and Therapeutics with a Focus on Hedgehog Signaling. Clin Cancer Res 18: 2429-2435. doi:10.1158/1078-0432.CCR-11-0755. PubMed: 22415315.
[45]
Karlou M, Lu JF, Wu G, Maity S, Tzelepi V et al. (2012) Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b. Prostate 72: 1638–47. PubMed: 22457212.
